4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-028827
Vice President, Finance sold 4,884 shares at $11.72 ($57,219)
From the SEC's structured data for this filing
Trades in this filing
Tourangeau Greg · Vice President, Finance
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-08 | Sale : show line 1 in the form | −4,884 | $11.72 | $57,219 | 11,807 | D |
| Open-market sales · 4,884 sh · avg $11.72 · $57,219 | ||||||
Loading xslF345X05/ownership.xml…